Learn About Our





We Are

Circadian Group

As a true pioneer in their field, the firm uses a comprehensive and integrated suite of online “pull” strategies to showcase a client’s value proposition and future prospects in an engaging format-- this is in contrast to the traditional sense of the term “IR” where Investor interest is anticipated versus cultivated.

Circadian prides itself on working with select small cap companies in the latter stages of early growth, which are working toward a near-term transformational catalyst to bolster an already distinguished track record of uncovering successful companies before Wall Street and the mainstream media

History From Our

Case Studies

Case Study #1



22nd Century Group is certainly the definition of a paradigm-shifting company ushering huge change in multiple industries. With multiple well-known catalysts for the Company in 2016, Circadian went to work to expose the symbol to as many retail investors as possible, again with the easy-to-understand article strategy. After 6 months’ worth of hard work, the company is delivering on promises with the stock in-tow, now approaching its 52 week high.

XXII recently re-hired Circadian for a second contract which is a testament to a job well done.

Program Statistics

Start Date: April 11, 2016         High Price: $1.39
Starting Price: $0.80                % Gain: 73.75%

Case Study #2



Advanced Medical Isotope, another paradigm-shifting company, is in the radio-brachytherapy device space—in the FDA process to bring a potentially safer and potentially more effective method for treating non-resectable tumors. As an injectable gel radiation that stays in-place after administration Circadian saw the huge potential to humanity if and once approved.

Approaching a potential final De Novo application for marketing clearance with the FDA in the near-future, Circadian is working under contract #2 with the Company to assist with broad global awareness and the reception by Wall street has been well received.

Program Statistics

Start Date: March 1, 2016       High Price: $0.0096
Starting Price: $0.0014              % Gain: 585.71%

Case Study #3



Circadian started with Propanc at a very dark time for the Company. At a fraction of a penny, a market cap of less than $1m and investments from quasi-destructive groups this was a very challenging situation for any Investor Relations firm.

After framing the interesting but complex attributes of the Company’s anti-cancer compound within the context of a series of easy to understand articles/ social media/ advertising, the Company’s stock became very active and their market cap increased a staggering 5,000%. During this time the Company was able to secure a well-termed mid-seven-figure financing deal with a large PE fund, usher their main product PRP through pre-clinicals and whole host of positive corporate development.

Program Statistics

Start Date: March 2, 2015       High Price: $0.135
Starting Price: $0.003              % Gain: 4,400%

Case Study #4



Circadian started with Endonovo in December, 2015 at a starting point of a flat-lined stock that had a great story to tell. Fast forward a few months, and the company, through as series of awareness tactics and informational articles, experienced a sizeable gain in both price per share and trading volume.

After mid-way into Circadian’s engagement the company secured significant funding and became significantly more active in corporate development. Endonovo seeks to engage in human trials of their device in short-order.

Program Statistics

Start Date: December 1, 2015        High Price: $0.99
Starting Price: $0.075                     % Gain: 1,220%

Get To Know

Our Team

Tyler Troup

Creative Director

Tyler is the driving vision behind what has evolved into Circadian Group today. In addition to providing senior leadership for the firm, Tyler is tasked with tending to the needs of current and potential clients as well as high-level strategy for awareness campaign management. Prior to founding Circadian Group, Tyler worked with another firm in the Investor Relations space. Prior to that Tyler worked on the sell-side for one of Canada’s largest financial institutions, BMO Nesbitt Burns. Tyler is a graduate of the Honours Business Commerce (Finance) program at the University of Windsor and has also passed his Canadian Securities Course (CSC). Tyler’s true passions are travelling to far-flung parts of the world with his wife and Boston terrier, Ari - he also enjoys boating the Great Lakes. As a self-described futurist, much of Tyler’s interest in emerging growth companies stems from a belief that recent advances in medicine will drastically improve life in the future.

Visit me on LinkedIn

Ryan Troup

President & COO

As President of Circadian Group, Ryan handles the day-to-day operations as well as the web-based infrastructure. Ryan has 10+ years of experience in the Micro and Small-Cap Natural Resource marketplace. Ryan studied Finance with a concentration in Financial Markets and Investments at Wayne State University and holds his Canadian Securities Course. Ryan’s skill sets include: Market Awareness, Media-Communications, Message Amplification, Communication and Leadership.

Visit me on LinkedIn

Jesseca Drouin

Chief Administrative Officer

Mateo Roksandic

Director of Digital

Sarah Ryrie

VP of Video Media & Copywriting




Contact Us

Get In touch

Your Name (required)

Your Email (required)


Your Message

Canada Office

3270 Electricity Drive, Ste. 213
Windsor, Ontario
N8W 5J1
+1 (647)-930-1037



2033 Main Street, Ste 408
Sarasota, Florida
+1 (305)-929-0440
Tadalafil, ampliamente conocido bajo su nombre promocionado Cialis comprar Cialis genérico sin receta en la farmacia Chemical peels with glycolic acid less traumatic buying Tretinoingeneric Tretinoin gel 0.05 mg, 0.1 mg Cialis vai al farmaco acquisto cialisyouth and beauty. Favorablement commander en ligne - meilleur prix cialis generique onlinelivraison en France Sie sollten Cialis nicht mit irgendeiner anderen Behandlung der erektilen Dysfunktion anwenden cialis tadalafil kaufen